Treatment with Tie2 activator Angpt-1 or AKB-9778 significantly attenuated the ability of plasma from severe COVID-19 or non–COVID-19 severe sepsis to promote procoagulant activity on endothelial cells (Figure 2 and Supplemental Figure 3). This evidence concerns the gene TEK and COVID-19.